BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27396607)

  • 1. Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience.
    Allali A; El-Mawardy M; Schwarz B; Sato T; Geist V; Toelg R; Richardt G; Abdel-Wahab M
    Cardiovasc Revasc Med; 2016 Sep; 17(6):391-8. PubMed ID: 27396607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of coronary angiography and intervention in patients previously treated by TAVI.
    Blumenstein J; Kim WK; Liebetrau C; Gaede L; Kempfert J; Walther T; Hamm C; Möllmann H
    Clin Res Cardiol; 2015 Aug; 104(8):632-9. PubMed ID: 25720330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves.
    Linke A; Woitek F; Merx MW; Schiefer C; Möbius-Winkler S; Holzhey D; Rastan A; Ender J; Walther T; Kelm M; Mohr FW; Schuler G
    Circ Cardiovasc Interv; 2012 Oct; 5(5):689-97. PubMed ID: 23048050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation.
    Gasparetto V; Fraccaro C; Tarantini G; Buja P; D'Onofrio A; Yzeiraj E; Pittarello D; Isabella G; Gerosa G; Iliceto S; Napodano M
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):376-83. PubMed ID: 22461314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement.
    Tanaka A; Jabbour RJ; Testa L; Agnifili M; Ettori F; Fiorina C; Adamo M; Bruschi G; Giannini C; Petronio AS; Barbanti M; Tamburino C; De Felice F; Reimers B; Poli A; Colombo A; Latib A
    Cardiovasc Revasc Med; 2019 May; 20(5):371-375. PubMed ID: 30857975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
    Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice.
    Van Mieghem NM; van der Boon RM; Faqiri E; Diletti R; Schultz C; van Geuns RJ; Serruys PW; Kappetein AP; van Domburg RT; de Jaegere PP
    JACC Cardiovasc Interv; 2013 Aug; 6(8):867-75. PubMed ID: 23871511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter aortic valve implantation in patients with severe aortic valve stenosis and large aortic annulus, using the self-expanding 31-mm Medtronic CoreValve prosthesis: first clinical experience.
    Nijhoff F; Agostoni P; Amrane H; Latib A; Testa L; Oreglia JA; De Marco F; Samim M; Bedogni F; Maisano F; Bruschi G; Colombo A; Van Boven AJ; Stella PR
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):492-9.e1. PubMed ID: 24263005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease.
    Abramowitz Y; Banai S; Katz G; Steinvil A; Arbel Y; Havakuk O; Halkin A; Ben-Gal Y; Keren G; Finkelstein A
    Catheter Cardiovasc Interv; 2014 Mar; 83(4):649-54. PubMed ID: 24532332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve.
    Geist V; Sherif MA; Khattab AA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):61-7. PubMed ID: 19089940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
    J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary obstruction following transcatheter aortic valve implantation: a systematic review.
    Ribeiro HB; Nombela-Franco L; Urena M; Mok M; Pasian S; Doyle D; DeLarochellière R; Côté M; Laflamme L; DeLarochellière H; Allende R; Dumont E; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 May; 6(5):452-61. PubMed ID: 23602458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter aortic valve implantation in patients with left main percutaneous coronary intervention.
    Cevallos J; Andrea R; Falces C; Martin-Yuste V; Freixa X; Vidal B; Brugaletta S; Castellá M; Masotti M; Sabaté M
    J Heart Valve Dis; 2013 Nov; 22(6):874-7. PubMed ID: 24597414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience.
    Cockburn J; Dooley M; Parker J; Hill A; Hutchinson N; de Belder A; Trivedi U; Hildick-Smith D
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):438-444. PubMed ID: 27315455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary angioplasty after self-expandable transcatheter aortic valve implantation.
    Greenberg G; Kornowski R
    J Invasive Cardiol; 2013 Jul; 25(7):361-3. PubMed ID: 23813067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Position of Edwards SAPIEN transcatheter valve in the aortic root in relation with the coronary ostia: implications for percutaneous coronary interventions.
    Katsanos S; Debonnaire P; van der Kley F; van Rosendael PJ; Joyce E; de Graaf MA; Schalij MJ; Scholte AJ; Bax JJ; Ajmone Marsan N; Delgado V
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):480-7. PubMed ID: 25367809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
    Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic-valve implantation with one single minimal contrast media injection.
    Arrigo M; Maisano F; Haueis S; Binder RK; Taramasso M; Nietlispach F
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1248-53. PubMed ID: 25545281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: Preliminary Experiences in China.
    Liao YB; Zhao ZG; Wei X; Xu YN; Zuo ZL; Li YJ; Zheng MX; Feng Y; Chen M
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):528-533. PubMed ID: 28318133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.